The role of vitamin D in psoriasis: a review
Authors:
- 20 January 2015
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 54 (4) , 383-392
Abstract
Background and objective: Psoriasis is a common, chronic autoimmune inflammatory skin disorder, which has potential systemic complications and is clinically defined by sharply demarcated, erythematous patches and plaques covered by a characteristic silvery white scale. Topical corticosteroids have widely been regarded as the mainstay first line of treatment. Recently, topical vitamin D analogs have been added to the first‐line treatment repertoire as well, either as monotherapy or in combination with topical steroids due to synergistic, complementary effectiveness. In this paper, we review the role of vitamin D in the pathophysiology and treatment of psoriasis.Methods: A comprehensive search of the Cochrane Library, MEDLINE, and PUBMED databases were performed to identify relevant basic science and clinical trial literature investigating the role of vitamin D in psoriasis. Primary endpoints in clinical trials were largely based on clinical improvement as assessed by the psoriasis area severity index score or physician's global assessment.Results and conclusion: The role of vitamin D in psoriasis is complex and extensive. Oral and topical vitamin D therapies provide comparable efficacies to corticosteroids when used as monotherapy and may be superior when used in combination with a potent topical steroid. Additionally topical vitamin D analogs demonstrate a favorable safety profile with “steroid‐sparing” effects. Thus, topical vitamin D derivatives should be considered an indispensable component of the current physician's arsenal in the treatment of psoriasis.Keywords
This publication has 61 references indexed in Scilit:
- Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control studyJournal of the American Academy of Dermatology, 2012
- Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine–Induced Proinflammatory S100 “Alarmins” Psoriasin (S100A7) and Koebnerisin (S100A15) in PsoriasisJournal of Investigative Dermatology, 2012
- Vitamin D metabolism and function in the skinMolecular and Cellular Endocrinology, 2011
- Vitamin D serum level changes in psoriatic patients treated with narrowband ultraviolet B phototherapy are related to the season of the irradiationPhotodermatology, Photoimmunology & Photomedicine, 2011
- Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapyPhotodermatology, Photoimmunology & Photomedicine, 2009
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- PsoriasisNew England Journal of Medicine, 2005
- Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skinJournal of the American Academy of Dermatology, 1997
- Safety and efficacy of oral calcitriol (1, 25 -dihydroxyvitamin D3) for the treatment of psoriasisBritish Journal of Dermatology, 1996
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979